Skip to content

Prepaid expenses at other companies

Eli Lilly logo
Eli LillyLLY
Corcept Therapeutics logo
Corcept TherapeuticsCORT
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
Arrowhead Research logo
Arrowhead ResearchARWR
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD

Other financials

Income statement

See full
Revenue$83.1M+38.3%
Gross profit$72.6M+41.2%
Operating income$7.9M+356%
Net income$2.2M+124%
EPS (diluted)$0.01+117%

Balance sheet

See full
Cash & equivalents$111.8M+91.2%
Total debt$258.6M-3.8%
Total equity$13.0M+137%
Total assets$392.0M+24.3%

Cash flow

See full
Operating cash flow$9.9M+198%
CapEx$131.0K
Free cash flow-$29.1M

Valuation

See full
Market cap$1.28B+18.3%
Enterprise value$1.42B+8.7%
P/E106.4×
P/S4.1×-0.8×

Profitability

See full
Gross margin85.9%+3.7pp
Operating margin11.4%+7.7pp
Net margin3.8%+2.1pp

Returns & leverage

See full
Return on equity-209.8%
Debt / equity19.9×
Current ratio2.1×+0.4×

Where this comes from

Reported directly by Xeris Biopharma Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseCurrent.

The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xeris Biopharma Holdings, Inc.'s prepaid expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xeris Biopharma Holdings, Inc.'s prepaid expenses?
Xeris Biopharma Holdings, Inc. (XERS) reported prepaid expenses of $9.4M in Q1 2026.
How has Xeris Biopharma Holdings, Inc.'s prepaid expenses changed year-over-year?
Xeris Biopharma Holdings, Inc.'s prepaid expenses increased by 55.8% year-over-year, from $6.03M to $9.4M.
What is the long-term trend for Xeris Biopharma Holdings, Inc.'s prepaid expenses?
Over 5 years (2020 to 2025), Xeris Biopharma Holdings, Inc.'s prepaid expenses has grown at a 24.5% compound annual growth rate (CAGR), from $3.2M to $9.55M.